Interactions between Gut Microbiota and Natural Bioactive Polysaccharides in Metabolic Diseases: Review
Nutrients · 24.08.2024 · 16 (17) · 2838
DOI: 10.3390/nu16172838 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Nutrients, online erschienen am 24.08.2024. Verfasst von Yu Pi und 10 weiteren Autor:innen. Beteiligte Einrichtung: Key Laboratory of Feed Biotechnology of Ministry of Agriculture and Rural Affairs, Institute of Feed Research, Chinese Academy of Agricultural Scienc…. Hauptthemen laut MEDLINE: Gastrointestinal Microbiome, Polysaccharides, Metabolic Diseases. Die Arbeit wurde bisher 40-mal zitiert (Crossref) und nennt 268 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Central Public-interest Scientific Institution Basal Research Fund, Agricultural Science and Technology Innovation Program of the Chinese Academy of Agricultural Sciences.
Abstract (Originalsprache)
The gut microbiota constitutes a complex ecosystem, comprising trillions of microbes that have co-evolved with their host over hundreds of millions of years. Over the past decade, a growing body of knowledge has underscored the intricate connections among diet, gut microbiota, and human health. Bioactive polysaccharides (BPs) from natural sources like medicinal plants, seaweeds, and fungi have diverse biological functions including antioxidant, immunoregulatory, and metabolic activities. Their effects are closely tied to the gut microbiota, which metabolizes BPs into health-influencing compounds. Understanding how BPs and gut microbiota interact is critical for harnessing their potential health benefits. This review provides an overview of the human gut microbiota, focusing on its role in metabolic diseases like obesity, type II diabetes mellitus, non-alcoholic fatty liver disease, and cardiovascular diseases. It explores the basic characteristics of several BPs and their impact on gut microbiota. Given their significance for human health, we summarize the biological functions of these BPs, particularly in terms of immunoregulatory activities, blood sugar, and hypolipidemic effect, thus providing a valuable reference for understanding the potential benefits of natural BPs in treating metabolic diseases. These properties make BPs promising agents for preventing and treating metabolic diseases. The comprehensive understanding of the mechanisms by which BPs exert their effects through gut microbiota opens new avenues for developing targeted therapies to improve metabolic health.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Key Laboratory of Feed Biotechnology of Ministry of Agriculture and Rural Affairs, Institute of Feed Research, Chinese Academy of Agricultural Sciences, Beijing 100081, China.
- Nutrilite Health Institute, Amway (Shanghai) Innovation & Science Co., Ltd., Shanghai 201203, China.
ORCID-Profile: Yu Pi, Liang Chen, Zhigang Zhu
Förderung
- National Natural Science Foundation of China
- Central Public-interest Scientific Institution Basal Research Fund
- Agricultural Science and Technology Innovation Program of the Chinese Academy of Agricultural Sciences
Zitieren
APA
Pi, Y., Fang, M., Li, Y., Cai, L., Han, R., Sun, W., Jiang, X., Chen, L., Du, J., Zhu, Z., & Li, X. (2024). Interactions between Gut Microbiota and Natural Bioactive Polysaccharides in Metabolic Diseases: Review. Nutrients, 16(17), 2838. https://doi.org/10.3390/nu16172838
Vancouver
Pi Y, Fang M, Li Y, Cai L, Han R, Sun W, et al. Interactions between Gut Microbiota and Natural Bioactive Polysaccharides in Metabolic Diseases: Review. Nutrients. 2024;16(17):2838. doi:10.3390/nu16172838
BibTeX
@article{Pi2024,
author = {Pi, Yu and Fang, Miaoyu and Li, Yanpin and Cai, Long and Han, Ruyi and Sun, Wenjuan and Jiang, Xianren and Chen, Liang and Du, Jun and Zhu, Zhigang and Li, Xilong},
title = {Interactions between Gut Microbiota and Natural Bioactive Polysaccharides in Metabolic Diseases: Review},
journal = {Nutrients},
year = {2024},
volume = {16},
number = {17},
pages = {2838},
doi = {10.3390/nu16172838}
}
EUVIMED